Chromocell Therapeutics Corporation (CHRO)

USD 1.35

(-1.01%)

Total Assets Summary of Chromocell Therapeutics Corporation

  • Chromocell Therapeutics Corporation's latest annual total assets in 2023 was 96.39 Thousand USD , up 75.02% from previous year.
  • Chromocell Therapeutics Corporation's latest quarterly total assets in 2024 Q2 was 2.6 Million USD , down -35.42% from previous quarter.
  • Chromocell Therapeutics Corporation reported annual total assets of 55.07 Thousand USD in 2022, down 0.0% from previous year.
  • Chromocell Therapeutics Corporation reported annual total assets of - USD in 2021, down -100.0% from previous year.
  • Chromocell Therapeutics Corporation reported quarterly total assets of 2.6 Million USD for 2024 Q2, down -35.42% from previous quarter.
  • Chromocell Therapeutics Corporation reported quarterly total assets of 96.39 Thousand USD for 2023 FY, up 75.02% from previous quarter.

Annual Total Assets Chart of Chromocell Therapeutics Corporation (2023 - 2020)

Historical Annual Total Assets of Chromocell Therapeutics Corporation (2023 - 2020)

Year Total Assets Total Assets Growth
2023 96.39 Thousand USD 75.02%
2022 55.07 Thousand USD 0.0%
2021 - USD -100.0%
2020 71.87 Thousand USD 0.0%

Peer Total Assets Comparison of Chromocell Therapeutics Corporation

Name Total Assets Total Assets Difference
AIM ImmunoTech Inc. 19.38 Million USD 99.503%
Ampio Pharmaceuticals, Inc. 5.73 Million USD 98.32%
Armata Pharmaceuticals, Inc. 109.96 Million USD 99.912%
Actinium Pharmaceuticals, Inc. 81.44 Million USD 99.882%
Azitra, Inc. 5.11 Million USD 98.116%
Can-Fite BioPharma Ltd. 9.98 Million USD 99.035%
Calidi Biotherapeutics, Inc. 10.01 Million USD 99.038%
CEL-SCI Corporation 30.52 Million USD 99.684%
iBio, Inc. 28.73 Million USD 99.665%
Lineage Cell Therapeutics, Inc. 101.01 Million USD 99.905%
MAIA Biotechnology, Inc. 7.56 Million USD 98.726%
Matinas BioPharma Holdings, Inc. 65.57 Million USD 99.853%
Navidea Biopharmaceuticals, Inc. 4.37 Million USD 97.795%
NovaBay Pharmaceuticals, Inc. 9.03 Million USD 98.933%
NanoViricides, Inc. 12.82 Million USD 99.248%
Oragenics, Inc. 4.96 Million USD 98.059%
BiomX Inc. 58.15 Million USD 99.834%
BiomX Inc. 58.15 Million USD 99.834%
Protalix BioTherapeutics, Inc. 84.43 Million USD 99.886%
Palatin Technologies, Inc. 10.74 Million USD 99.103%
Scorpius Holdings, Inc. 51.03 Million USD 99.811%
Theriva Biologics, Inc. 60.21 Million USD 99.84%